Other Relevant News
CNN, August 6, 2020
Four cancer patients in end-of-life care will be become the first people in decades to legally possess and consume psilocybin mushrooms in Canada after a landmark decision.
New Atlas, July 23, 2020
A new review from neuroethicist Eddie Jacobs, and published in the Journal of Psychedelic Studies, is suggesting psilocybin may have great potential as a treatment for obsessive-compulsive disorder (OCD).
The Guardian, July 4, 2020
As more troops self-medicate with psychedelic drugs to help with PTSD, a group of experts lobby for proper clinical trials.
Dr Robin Carhart-Harris, The Guardian, June 8, 2020
Imperial College, UK have been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing
Dr Robin Carhart-Harris is a member of the Mind Medicine Australia advisory panel.
Dr Tony Bartone, Professor Ian Hickie AM, Professor Patrick McGorry AO, AMA Joint Statement, June 2, 2020
Australia will likely see increases in youth suicide and a surge in demand for specialist mental health services as the full and lasting impact of the COVID-19 pandemic is experienced across the community.
David H., The Cannabis Investor, May 27, 2020
Organizations forming today will build the infrastructure which, three to five years from now, will be delivering psychedelic medicines to the world.
Interim Analysis Shows At Least 90% Chance of Statistically Significant Difference in PTSD Symptoms after MDMA-assisted Psychotherapy
Brad Burge, Multidisciplinary Association for Psychedelic Studies (MAPS), May 13, 2020
Results are the strongest confirmation that an interim analysis can provide
Beckley Foundation, November 17, 2017
Watch our brains become more connected on psilocybin, and learn how psychedelics can help treat conditions such as depression, addiction, and PTSD.
Dr Norman Swan, On Breakfast Program with Hamish Macdonald, ABC Radio National, November 11, 2019
Research into psychedelic drugs like LSD is growing, encouraged by positive early trials. Scientists think these drugs could treat things like post-traumatic stress disorder and depression.
Sam Levin, The Guardian, June 5, 2019
Yesterday Oakland became the second city in the US to decriminalize magic mushrooms and other psychedelics.
Johns Hopkins and NYU studies in psilocybin as a treatment for cancer-related psychological distress.
News outlets included CNN, New York Times, Newsweek, PBS Newshour, Science, Scientific American, The Atlantic, The Guardian, Time, and USA Today, among others.
Two clinical studies (released Dec. 1, 2016) examining the effect of psilocybin on symptoms of depression and anxiety in people with life-threatening cancer were released and covered by a number of media.
Vox June 27, 2016
Show Me the Evidence staff examines more than 50 studies analyzing the safety and efficacy of psychedelic drugs and psychedelic-assisted therapy and interviews researchers involved in the work. Vox, 2016
Zoe Cormier, Nature, May 17, 2016
Imperial College study provides preliminary support for the safety and efficacy of psilocybin as a therapy for treatment-resistant depression. Nature, 2016
Douglas Main, Newsweek, April 19, 2016
Researchers at the University of Zurich show that a small amount of psilocybin can reduce the distress caused by mild social exclusion and lessens activity in the area of the brain associated with this emotion. Newsweek, 2016
The Lancet Psychiatry, April 5, 2016
Drug-assisted psychotherapy as a possible alternative to existing pharmacological and psychological treatments. (Free registration required)
Washingtonian, January 7, 2014
Recent John’s Hopkins study on effecting addictive behaviour with psychedelics. Washingtonian, 2014